E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/29/2016 in the Prospect News PIPE Daily.

OncoCyte secures $10.55 million through private placement of units

Company sells units of shares, five-year warrants at $3.25 per unit

By Devika Patel

Knoxville, Tenn., Aug. 29 – OncoCyte Corp. completed a $10.55 million private placement of units on Aug. 29, according to an 8-K filed Monday with the Securities and Exchange Commission. Cowen and Co., LLC was the agent.

The company sold 3,246,153 units of one common share and one warrant at $3.25 per unit.

Each five-year warrant is exercisable at $3.25. The strike price is a 19.15% discount to the Aug. 26 closing share price of $4.02.

George Karfunkel invested $3.25 million.

Proceeds will be used for operations, working capital and general corporate purposes.

The biotechnology company is based in Alameda, Calif.

Issuer:OncoCyte Corp.
Issue:Units of one common share and one warrant
Amount:$10,549,997
Units:3,246,153
Price:$3.25
Warrants:One warrant per unit
Warrant expiration:Five years
Warrant strike price:$3.25
Agent:Cowen and Co., LLC
Investor:George Karfunkel (for $3.25 million)
Settlement date:Aug. 29
Stock symbol:NYSE: OCX
Stock price:$4.02 at close Aug. 26
Market capitalization:$101.2 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.